4//SEC Filing
Kyrillos Jean-Claude 4
Accession 0001438133-25-000177
CIK 0001438133other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:21 PM ET
Size
8.9 KB
Accession
0001438133-25-000177
Insider Transaction Report
Form 4
Kyrillos Jean-Claude
EVP & Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2025-10-15$14.75/sh−1,301$19,190→ 22,384 total - Exercise/Conversion
Common Stock
2025-10-15+3,636→ 23,685 total - Exercise/Conversion
Restricted Stock Unit
2025-10-15−3,636→ 25,453 total→ Common Stock (3,636 underlying)
Footnotes (4)
- [F1]Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F2]Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F3]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001804186
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 4:21 PM ET
- Size
- 8.9 KB